| Literature DB >> 29790605 |
Paola Cura Daball1, Monica Sofia Ventura Ferreira2, Sandra Ammann1, Christian Klemann1,3, Myriam R Lorenz4, Ursula Warthorst1, Timothy Ronan Leahy5, Niall Conlon6, Justin Roche7, Pere Soler-Palacín8, Marina Garcia-Prat8, Ilka Fuchs1, Sebastian Fuchs1, Fabian Beier2, Tim H Brümmendorf2, Carsten Speckmann1,3, Peter Olbrich9, Olaf Neth9, Klaus Schwarz4,10, Stephan Ehl1,3, Anne Rensing-Ehl1.
Abstract
Premature T-cell immunosenescence with CD57+ CD8+ T-cell accumulation has been linked to immunodeficiency and autoimmunity in primary immunodeficiencies including activated PI3 kinase delta syndrome (APDS). To address whether CD57 marks the typical senescent T-cell population seen in adult individuals or identifies a distinct population in APDS, we compared CD57+ CD8+ T cells from mostly pediatric APDS patients to those of healthy adults with similarly prominent senescent T cells. CD57+ CD8+ T cells from APDS patients were less differentiated with more CD27+ CD28+ effector memory T cells showing increased PD1 and Eomesodermin expression. In addition, transition of naïve to CD57+ CD8+ T cells was not associated with the characteristic telomere shortening. Nevertheless, they showed the increased interferon-gamma secretion, enhanced degranulation and reduced in vitro proliferation typical of senescent CD57+ CD8+ T cells. Thus, hyperactive PI3 kinase signaling favors premature accumulation of a CD57+ CD8+ T-cell population, which shows most functional features of typical senescent T cells, but is different in terms of differentiation and relative telomere shortening. Initial observations indicate that this specific differentiation state may offer the opportunity to revert premature T-cell immunosenescence and its potential contribution to inflammation and immunodeficiency in APDS.Entities:
Keywords: Activated PI3Kdelta syndrome; CD57; T-cell differentiation; T-cell senescence; immunodeficiency; telomeres
Mesh:
Substances:
Year: 2018 PMID: 29790605 DOI: 10.1111/imcb.12169
Source DB: PubMed Journal: Immunol Cell Biol ISSN: 0818-9641 Impact factor: 5.126